TrademarkDir
EAS
LIVE

Serial Number

75079792

Owner

EASTERN ANALYTICAL SERVICES, INC.

Attorney

Stewart J. Bellus

Filing Date

Mar 28, 1996

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EAS Trademark

Serial Number: 75079792 • Registration: 2037208

EAS is a trademark filed by EASTERN ANALYTICAL SERVICES, INC. on March 28, 1996. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

EASTERN ANALYTICAL SERVICES, INC. (2 trademarks)

4 Westchester Plaza
Elmsford, NY 105231601

Entity Type: 03

Trademark Details

Filing Date

March 28, 1996

Registration Date

February 11, 1997

Published for Opposition

November 19, 1996

Goods & Services

evaluating and testing residential, commercial and industrial buildings for asbestos [, radon gas, hydrocarbons ] and other substances hazardous to human health

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
Jun 29, 2016 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Jun 29, 2016 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jun 29, 2016 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 29, 2016 APRE
TEAS SECTION 8 & 9 RECEIVED
Apr 11, 2016 E89R
CASE FILE IN TICRS
Dec 20, 2006 CFIT
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Nov 29, 2006 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Nov 29, 2006 89AG
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Aug 29, 2006 89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Aug 29, 2006 89AF
TEAS SECTION 8 & 9 RECEIVED
Aug 29, 2006 E89R
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 19, 2003 C15A
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jan 23, 2003 815F
PAPER RECEIVED
Jan 23, 2003 MAIL
REGISTERED-PRINCIPAL REGISTER
Feb 11, 1997 R.PR
PUBLISHED FOR OPPOSITION
Nov 19, 1996 PUBO
NOTICE OF PUBLICATION
Oct 18, 1996 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 1996 CNSA
ASSIGNED TO EXAMINER
Sep 9, 1996 DOCK

Related Trademarks

More from this Owner

LEAD RX

LEAD RX

LEAD RX

LEAD RX

LEAD RX

LEAD RX